Finn Haley

Finn Haley

SVP, Corporate Development at Edwards Lifesciences

Podcasts

Build-to-Buy and Option Structures

M&A is inherently risky, but the rewards of a successful deal can exponentially grow a company overnight. There are many things to consider before closing a transaction, and big companies are finding new deal structures to minimize risks when doing acquisitions. In this episode, Finn Haley, SVP of Corporate Development at Edwards Lifesciences, discusses the build-to-buy option structure they use in the healthcare industry.

guests:
Finn Haley
SVP, Corporate Development at Edwards Lifesciences
19 Jun
live-podcasts
strategy

Plays

No items found.